Inhibition of Intra-Abdominal Adhesion Formation With the Angiogenesis Inhibitor Sunitinib

Journal of Surgical Research

Volumn 149, Issue 1, 2008, Pages 115-119

  Kim, Sendia ^a   Lee, Sang ^a   Greene, Arin K ^a   Arsenault, Danielle A ^a   Le, Hau ^a   Meisel, Jonathan ^a   Novak, Katherine ^a   Flynn, Evelyn ^a   Heymach, John V ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

adhesions; angiogenesis; sunitinib; VEGF

Indexed keywords

METHYLCELLULOSE; SUNITINIB;

ABDOMINAL ADHESION; ABDOMINAL DISEASE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CONTROLLED STUDY; DRUG EFFECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ABDOMINAL CAVITY; ADHESIONS; ADMINISTRATION, ORAL; ANGIOGENESIS INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; INDOLES; MICE; MICE, INBRED C57BL; PYRROLES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 48949105307     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.10.010     Document Type: Article

References (38)

1. Menzies D., and Ellis H. Intestinal obstruction from adhesions-how big is the problem?. Ann R Coll Surg Engl 72 (1990) 60
2. Ray N.F., Denton W.G., Thamer M., et al. Abdominal adhesiolysis: Inpatient care and expenditures in the United States in 1994. J Am Coll Surg 186 (1998) 1
3. Menzies D., Parker M., Hoare R., et al. Small bowel obstruction due to postoperative adhesions: Treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl 83 (2001) 40
4. Haney A.F., and Doty E. The formation of coalescing peritoneal adhesions requires injury to both contacting peritoneal surfaces. Fertil Steril 61 (1994) 767
5. diZerega G.S., and Campeau J.D. Peritoneal repair and postsurgical adhesion formation. Hum Reprod Update 7 (2001) 547
6. Montz F.J., Holschneider C.H., Bozuk M., et al. Interleukin 10: Ability to minimize postoperative intraperitoneal adhesion formation in a murine model. Fertil Steril 61 (1994) 1136
7. Rodgers K.E., Johns D.B., Girgis W., et al. Reduction of adhesion formation with hyaluronic acid after peritoneal surgery in rabbits. Fertil Steril 67 (1997) 553
8. Greene A.K., Alwayn I.P., Nose V., et al. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib. Ann Surg 242 (2005) 140
9. Chiang S.C., Cheng C.H., Moulton K.S., et al. TNP-470 inhibits intraabdominal adhesion formation. J Pediatr Surg 35 (2000) 189
10. Wiczyk H.P., Grow D.R., Adams L.A., et al. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril 69 (1998) 511
11. Chegini N. The role of growth factors in peritoneal healing: Transforming growth factor beta (TGF-β). Eur J Surg Suppl 577 (1997) 17
12. Rout U.K., Oommen K., and Diamond M.P. Altered expressions of VEGF mRNA splice variants during progression of uterine-peritoneal adhesions in the rat. Am J Reprod Immunol 43 (2000) 299
13. Morimoto A.M., Tan N., West K., et al. Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor. Oncogene 23 (2004) 1618
14. Takahashi H., Obata R., and Tamaki Y. A novel vascular endothelial growth factor receptor 2 inhibitor, SU11248, suppresses choroidal neovascularization in vivo. J Ocul Pharmacol Ther 22 (2006) 213
15. Pietras K., and Hanahan D. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. J Clin Oncol 23 (2005) 939
16. Winston R.M., and Margara R.A. Microsurgical salpingostomy is not an obsolete procedure. Br J Obstet Gynaecol 98 (1991) 637
17. Risberg B. Adhesions: Preventive strategies. Eur J Surg Suppl 577 (1997) 32
18. Rose B.I., MacNeill C., Larrain R., et al. Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. A randomized comparison of the effect on weight change. J Reprod Med 36 (1991) 537
19. Verco S.J., Peers E.M., Brown C.B., et al. Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: Preclinical studies. Hum Reprod 15 (2000) 1764
20. Wiseman D.M., Trout J.R., and Diamond M.P. The rates of adhesion development and the effects of crystalloid solutions on adhesion development in pelvic surgery. Fertil Steril 70 (1998) 702
21. Metwally M., Watson A., Lilford R., et al. Fluid and pharmacological agents for adhesion prevention after gynecological surgery. Cochrane Database Syst Rev (2006) CD001298.
22. diZerega G.S., Verco S.J., Young P., et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynecological surgery. Hum Reprod 17 (2002) 1031
23. Siegler A.M., Kontopoulos V., and Wang C.F. Prevention of postoperative adhesions in rabbits with ibuprofen, a nonsteroidal anti-inflammatory agent. Fertil Steril 34 (1980) 46
24. Holtz G. Failure of a nonsteroidal anti-inflammatory agent (ibuprofen) to inhibit peritoneal adhesion reformation after lysis. Fertil Steril 37 (1982) 582
25. Luciano A.A., Hauser K.S., and Benda J. Evaluation of commonly used adjuvants in the prevention of postoperative adhesions. Am J Obstet Gynecol 146 (1983) 88
26. Rodgers K.E., Johns D.B., Girgis W., et al. Prevention of adhesion formation with intraperitoneal administration of tolmetin and hyaluronic acid. J Invest Surg 10 (1997) 367
27. Watson A., Vandekerckhove P., and Lilford R. Liquid and fluid agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst Rev (2000) CD001298.
28. Hellebrekers B.W., Trimbos-Kemper T.C., Trimbos J.B., et al. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril 74 (2000) 203
29. Aarons C.B., Cohen P.A., Gower A., et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 245 (2007) 176
30. Ferrara N., Houck K., Jakeman L., et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 (1992) 18
31. Robinson C.J., and Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114 (2001) 853
32. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376 (1995) 62
33. Carmeliet P., Ferreira V., Breier G., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435
34. Ferrara N., Carver-Moore K., Chen H., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439
35. Gerber H.P., Hillan K.J., Ryan A.M., et al. VEGF is required for growth and survival in neonatal mice. Development 126 (1999) 1149
36. Ferrara N., Chen H., Davis-Smyth T., et al. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4 (1998) 336
37. Diamond M.P., El-Hammady E., Munkarah A., et al. Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril 83 (2005) 405
38. Saltzman A.K., Olson T.A., Mohanraj D., et al. Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model. Am J Obstet Gynecol 174 (1996) 1502